Update on diffuse alveolar hemorrhage and pulmonary vasculitis.

ABSTRACT: Diffuse alveolar hemorrhage is a clinical syndrome that can be a manifestation of multiple different causes. Identification of the underlying etiology is of utmost importance and dictates treatment. Pulmonary vasculitis including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a common cause of diffuse alveolar hemorrhage. For AAV, treatment includes induction followed by maintenance therapy. Rituximab has an increasing role in the treatment of AAV.

SUBMITTER: Krause ML 

PROVIDER: S-EPMC3483562 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature